ACR blasts breast imaging study as misleading

Article

The American College of Radiology criticized a study by the Agency for Healthcare Research and Quality that found current noninvasive imaging cannot replace biopsy to exclude or confirm breast cancer.

The American College of Radiology criticized a study by the Agency for Healthcare Research and Quality that found current noninvasive imaging cannot replace biopsy to exclude or confirm breast cancer.

The report, Effectiveness of noninvasive diagnostic tests for breast abnormalities, stated that the accuracy of scintimammography, PET, ultrasound, and MRI is suboptimal compared with biopsy.

Officials in the ACR said that breast imagers are well acquainted with the protocol regarding a suspicious mammographic finding, which generally calls for biopsy. The college also expressed concern that the report would mislead women into foregoing additional imaging after an inconclusive screening mammogram.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.